BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36232418)

  • 21. Subtle endoscopic manifestations of diffuse signet cell gastric adenocarcinoma in patients with CDH1 mutations.
    Ladabaum U; Ford JM; Poultsides G; Norton J
    Gastrointest Endosc; 2021 Dec; 94(6):1146-1147. PubMed ID: 34416278
    [No Abstract]   [Full Text] [Related]  

  • 22. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
    Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
    Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
    Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole Exome Sequencing Study Suggests an Impact of
    Nurgalieva A; Galliamova L; Ekomasova N; Yankina M; Sakaeva D; Valiev R; Prokofyeva D; Dzhaubermezov M; Fedorova Y; Khusnutdinov S; Khusnutdinova E
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing.
    Nemtsova MV; Kalinkin AI; Kuznetsova EB; Bure IV; Alekseeva EA; Bykov II; Khorobrykh TV; Mikhaylenko DS; Tanas AS; Kutsev SI; Zaletaev DV; Strelnikov VV
    Sci Rep; 2020 Jan; 10(1):504. PubMed ID: 31949278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
    Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
    Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.
    Guindalini RSC; Cormedi MCV; Maistro S; Pasini FS; Branas PCAA; Dos Santos L; de Lima Pereira GF; de Bock GH; Saccaro DM; Katayama MLH; Faraj SF; Safatle-Ribeiro A; Ribeiro Junior U; Diz MDPE; de Gouvêa ACRC; Chammas R; Folgueira MAAK
    Gastric Cancer; 2019 Sep; 22(5):920-931. PubMed ID: 30895400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.
    Liu H; Li F; Zhu Y; Li T; Huang H; Lin T; Hu Y; Qi X; Yu J; Li G
    Oncotarget; 2016 Jul; 7(28):43894-43906. PubMed ID: 27270314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients.
    Kim S; Chung JW; Jeong TD; Park YS; Lee JH; Ahn JY; Kim DH; Choi KD; Lee W; Song HJ; Lee GH; Chun S; Jung HY; Min WK; Kim JH
    Fam Cancer; 2013 Sep; 12(3):503-7. PubMed ID: 23264079
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Ben Aissa-Haj J; Kabbage M; Othmen H; Saulnier P; Kettiti HT; Jaballah-Gabteni A; Ferah A; Medhioub M; Khsiba A; Mahmoudi M; Maaloul A; Ben Nasr S; Chelbi E; Abdelhak S; Boubaker MS; Azzouz MM; Rouleau E
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
    Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
    Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
    Humar B; Guilford P
    Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Corso G; Magnoni F; Massari G; Trovato CM; De Scalzi AM; Vicini E; Bonanni B; Veronesi P; Galimberti V; Bagnardi V
    J Med Genet; 2022 Apr; 59(4):313-317. PubMed ID: 34952833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 40. Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma.
    Jacobs G; Hellmig S; Huse K; Titz A; Franke A; Kwiatkowski R; Ott S; Kosmahl M; Fischbach W; Lucius R; Klapper W; Fölsch UR; Hampe J; Schreiber S; Rosenstiel P
    Haematologica; 2011 Jul; 96(7):987-95. PubMed ID: 21459793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.